HIT-HARD Trial Protocol Tests Short-Course High-Dose Antibiotics
The HIT-HARD trial protocol outlines a phase III study testing if short-course, high-dose beta-lactam therapy is non-inferior to conventional regimens ...
Tag: Short-course treatment
Platelet Count Rose Rapidly After Caplacizumab in Refractory iTTP Case
A 53-year-old woman with plasma-exchange-refractory immune-mediated thrombotic thrombocytopenic purpura achieved rapid platelet recovery following five daily doses of caplacizumab alongside ...
POPULAR NEWS
-
Kenyan Study Tracks Oral HPV Dynamics Across Eighteen Months
-
Mobile Health Coaching Cuts Gestational Diabetes Risk in High-Risk Pregnancies
-
Machine Learning Links Metabolic and Inflammatory Shifts to Age-Related Hearing Loss
-
Continuous Infusion and Monitoring May Optimize Aztreonam and Ceftazidime-Avibactam Dosing